PrimeX News

Broker News

Silver (XAG) Forecast: Silver Outlook Hinges on Inflation, Yields and Fed Signals
Sun, 17 May 2026 21:38:21 GMT
Gold (XAUUSD) Price Forecast: Will Rising Yields Push Gold Toward 52-Week MA
Sun, 17 May 2026 20:13:17 GMT
The Week Ahead: Oil, Yields and Nvidia Earnings Drive Pivotal Week for Stocks
Sun, 17 May 2026 18:23:37 GMT
Silver Price Forecast: Is XAGUSD Set for a Bigger Drop Before the Next Rally?
Sun, 17 May 2026 18:29:27 GMT
Supertrend Indicator Explained: Formula, Trading Strategy, Pros & Cons
Sun, 17 May 2026 13:41:20 GMT
Bitcoin Weekly Outlook: NVIDIA Earnings in Main Focus as BTC Price Eyes Dip
Sun, 17 May 2026 11:36:26 GMT

ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 30 Apr 2026 13:08:34 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Mon, 13 Apr 2026 16:16:44 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 26 Mar 2026 21:25:31 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Mon, 16 Mar 2026 13:30:15 GMT
Jobs Miss and Oil Spike Signal Stagflation Risk for U.S. Economy
Fri, 20 Mar 2026 20:24:14 GMT

How Renko Charts Filter Market Noise & Improve Trend Analysis
Sun, 10 May 2026 14:02:44 GMT
Getting an Edge From Factor Investing
Sat, 09 May 2026 10:43:54 GMT
US Sector Rotation Strategy: Using the Business Cycle & RRG Charts to Find Market Leaders
Sun, 03 May 2026 16:49:46 GMT
Silver (XAG) Forecast: Weak Below 50-Day MA, Silver Analysis Signals More Downside
Tue, 21 Apr 2026 17:29:23 GMT
What Are Leveraged and Inverse ETFs? Risks, Rewards, and Key Strategies
Mon, 23 Mar 2026 23:55:30 GMT
Bollinger Bands Trading Strategies: How to Read Volatility, Identify Market Regimes, and Trade with a Statistical Edge
Fri, 13 Mar 2026 22:59:16 GMT

SLN

Silence Therapeutics Plc - ADR

6.10

USD

Silence Therapeutics Plc - ADR Profile

About

Silence Therapeutics plc focuses on the discovery, development and delivery of novel RNA therapeutics in hematology, cardiovascular and other rare and metabolic indications. The Company's product candidate consist SLN124 for the treatment of iron overload disorders; SLN360 for the cardiovascular disease with high lipoprotein and SLN500 for the treatment of complement-mediated diseases which are in clinical stage. Silence Therapeutics plc is based in London, the United Kingdom.

Info & Links

CEO

Iain Ross

Headquarters

12 HAMMERSMITH GROVE, OFFICE 205
LONDON, X0 W6 7AP, UNITED KINGDOM

Auditor

PricewaterhouseCoopers LLP

Share holders

1,259

Employees

Silence Therapeutics Plc - ADR Statistics

Valuation Measures

Market Capitalization²

288.37M

Enterprise Value

277.09M

Enterprise Value/EBITDA(ttm)

-3.06

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

490.08

Price to Book(mrq)

4.40

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

62.12%

Operating Margin(ttm)

-15615.03%

Profit Margin(ttm)

-20025.48%

Return on Equity(ttm)

-101.71%

Return on Invested Capital(ttm)

-101.55%

Return on Assets(ttm)

-55.53%

Income Statement

Revenue(ttm)

559.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

344.00K

EBITDA(ttm)³

-90.52M

Net Income Available to Common(ttm)

-88.61M

Diluted EPS(ttm)

-1.87

Share Statistics

Beta (5Y Monthly)

1.33

52-Week Change

39.59%

S&P 500 52-Week Change

24.23%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

47.23M

Dividend Yield

0.00%

Float⁴

45.30M

% Held by Insiders

4.10%

% Held by Institutions

98.73%

Balance Sheet

Total Cash(mrq)

85.11M

Total Cash Per Share(mrq)

1.80

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.72%

Quick Ratio(mrq)

8.72%

Book Value Per Share(mrq)

1.32

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.32

Free Cash Flow(ytd)

-62.33M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SLN